» Articles » PMID: 15352249

Identification of Metastasis-associated Proteins in a Human Tumor Metastasis Model Using the Mass-mapping Technique

Overview
Journal Proteomics
Date 2004 Sep 8
PMID 15352249
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

For most cancer cell types, the acquisition of metastatic ability leads to clinically incurable disease. The identification of molecules whose expression is specifically correlated with the metastatic spread of cancer would facilitate the design of therapeutic interventions to inhibit this lethal process. In order to facilitate metastasis gene discovery we have previously characterized a pair of monoclonal cell lines from the human breast carcinoma cell line MDA-MB-435 that have different metastatic phenotypes in immune-compromised mice. In this study, serum-free conditioned media was collected from the cultured monoclonal cell lines and a mass mapping technique was applied in order to profile a component of each cell line proteome. We utilized chromatofocusing in the first dimension to obtain a high resolution separation based on protein pI, and nonporous silica reverse-phase high performance liquid chromatography was used for the second dimension. Selected proteins were identified on the basis of electrospray ionization time of flight mass spectrometry (ESI-TOF MS) intact protein mapping and matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF MS) peptide mass fingerprinting. Using this approach we were able to map over 400 proteins and plot them as a 2-D map of pI versus accurate M(r). This was performed over a pI range of 4.0-6.2, and a mass range of 6-80 kDa. ESI-TOF MS data and further analysis using MALDI-TOF MS confirmed and identified 27 differentially expressed proteins. Proteins associated with the metastatic phenotype included osteopontin and extracellular matrix protein 1, whereas the matrix metalloproteinase-1 and annexin 1 proteins were associated with the non-metastatic phenotype. These findings demonstrate that the mass mapping technique is a powerful tool for the detection and identification of proteins in complex biological samples and which are specifically associated with a cellular phenotype.

Citing Articles

NADH-Cytochrome b5 Reductase 3 Promotes Colonization and Metastasis Formation and Is a Prognostic Marker of Disease-Free and Overall Survival in Estrogen Receptor-Negative Breast Cancer.

Lund R, Leth-Larsen R, Di Caterino T, Terp M, Nissen J, Laenkholm A Mol Cell Proteomics. 2015; 14(11):2988-99.

PMID: 26351264 PMC: 4638041. DOI: 10.1074/mcp.M115.050385.


miR-155, identified as anti-metastatic by global miRNA profiling of a metastasis model, inhibits cancer cell extravasation and colonization in vivo and causes significant signaling alterations.

Thomsen K, Terp M, Lund R, Sokilde R, Elias D, Bak M Oncotarget. 2015; 6(30):29224-39.

PMID: 26317550 PMC: 4745722. DOI: 10.18632/oncotarget.4942.


Differential expression of genes associated with the progression of renal disease in the kidneys of liver-specific glucokinase gene knockout mice.

Xu W, Li H, Wang R, Lei Z, Mao Y, Wang X Int J Mol Sci. 2013; 14(3):6467-86.

PMID: 23519111 PMC: 3634482. DOI: 10.3390/ijms14036467.


An optimized isolation of biotinylated cell surface proteins reveals novel players in cancer metastasis.

Karhemo P, Ravela S, Laakso M, Ritamo I, Tatti O, Makinen S J Proteomics. 2012; 77:87-100.

PMID: 22813880 PMC: 3508169. DOI: 10.1016/j.jprot.2012.07.009.


Differential secretome analysis reveals CST6 as a suppressor of breast cancer bone metastasis.

Jin L, Zhang Y, Li H, Yao L, Fu D, Yao X Cell Res. 2012; 22(9):1356-73.

PMID: 22688893 PMC: 3434352. DOI: 10.1038/cr.2012.90.


References
1.
Mignatti P, Morimoto T, Rifkin D . Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is released by cells via a pathway independent of the endoplasmic reticulum-Golgi complex. J Cell Physiol. 1992; 151(1):81-93. DOI: 10.1002/jcp.1041510113. View

2.
Sage E . Terms of attachment: SPARC and tumorigenesis. Nat Med. 1997; 3(2):144-6. DOI: 10.1038/nm0297-144. View

3.
Jiang D, Ying W, Lu Y, Wan J, Zhai Y, Liu W . Identification of metastasis-associated proteins by proteomic analysis and functional exploration of interleukin-18 in metastasis. Proteomics. 2003; 3(5):724-37. DOI: 10.1002/pmic.200300411. View

4.
Triantafilou M, Triantafilou K . Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster. Trends Immunol. 2002; 23(6):301-4. DOI: 10.1016/s1471-4906(02)02233-0. View

5.
Mehul B, Hughes R . Plasma membrane targetting, vesicular budding and release of galectin 3 from the cytoplasm of mammalian cells during secretion. J Cell Sci. 1997; 110 ( Pt 10):1169-78. DOI: 10.1242/jcs.110.10.1169. View